A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain-Reference-Cited by-同舟云学术

A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain

Published:2005-03 Issue:3 Volume:23 Page:275-287
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:Pharmacoeconomics

Author:

Tárraga-López Pedro J.,Celada-Rodríguez Ángel,Cerdán-Oliver Miguel,Solera-Albero Juan,Ocaña-López José M.,López-Cara Mateo A.,De Miguel-Clave Jaime

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/content/pdf/10.2165/00019053-200523030-00007.pdf

Reference55 articles.

1. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Star Q 1938; 41: 155–78

2. Garcia Gil C, Cortés M. Comparación de las tendencies de mortalidad per enfermedades isquémicas del corazón y otras cardiovasculares entre Espana y cites paises desarrollados 1970-1980. Med Clin (Bare) 1989; 93: 790–8

3. World Health Organization. World health statistics annual 1990. Geneva: WHO, 1991

4. Olalla MT, Almazán J, Sierra MJ, et al. Mortalidad per enfermedad isquémica del corazón. Bel Epidemiol Semanal 1996; 4: 213–9

5. Banegas JR, Rodríguez Artalejo F, Rodríguez Pérez P, et al. Recent coronary heart disease mortality trends in Spain. Int J Epidemiol 1990; 19: 761–2

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Evaluations Informed Exclusively by Real World Data: A Systematic Review;International Journal of Environmental Research and Public Health;2020-02-12

2. Analysis of Cost of Illness, Treatment, Complications, and Interventions of Hypercolesterolemia in Mexico in 2016;Value in Health Regional Issues;2018-12

3. Lipid lowering efficacy of atorvastatin;Cochrane Database of Systematic Reviews;2012-12-12

4. Aspectos clínicos e socioeconômicos das dislipidemias em portadores de doenças cardiovasculares;Physis: Revista de Saúde Coletiva;2011

5. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea;Clinical Therapeutics;2009-10